Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCD | O00767 | 19/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL242539 | 0.92 | SCD (0.78) | SCD | |
| SCHEMBL244786 | 0.89 | SCD (0.81) | SCD | |
| SCHEMBL243719 | 0.85 | SCD (0.76) | SCD | |
| SCHEMBL246305 | 0.84 | SCD (0.82) | SCD | |
| SCHEMBL243008 | 0.81 | SCD (1.00) | SCD | |
| SCHEMBL241995 | 0.81 | SCD (0.77) | SCD | |
| SCHEMBL245140 | 0.81 | SCD (0.83) | SCD | |
| SCHEMBL243777 | 0.80 | SCD (0.76) | SCD | |
| SCHEMBL1912034 | 0.79 | SCD (0.77) | SCD | |
| SCHEMBL242641 | 0.79 | SCD (0.58) | SCD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2054408-A2 | HETEROCYCLIC COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RELATED TO ELEVATED LIPID LEVEL | Novartis Ag (CH) | 2009-05-06 | — | — | EP | disclosed |
| WO-2008127349-A2 | HETEROCYCLIC COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RELATED TO ELEVATED LIPID LEVEL | NOVARTIS AG (CH) | 2008-10-23 | — | — | WO | disclosed |